Jim Wilson Praises iECURE's Milestone in Gene Therapy with ECUR-506 for OTCD Dr. Jim Wilson, a gene therapy innovator, shares insights on iECURE's promising results for ECUR-506 in treating Ornithine Transcarbamylase Deficiency, marking a key milestone in biotechnology.

Jim Wilson Praises iECURE's Milestone in Gene Therapy with ECUR-506 for OTCD #USA #Philadelphia #GEMMA_Biotherapeutics #iECURE #OTCD